(S (NP (NNP Psoas) (NN muscle) (NNS measurements)) (VP (VBP are) (ADVP (RB frequently)) (VP (VBN used) (PP (IN as) (NP (NP (NP (NNS markers)) (PP (IN of) (NP (NN sarcopenia)))) (CC and) (NP (NP (NNS predictors)) (PP (IN of) (NP (NN health)))))))) (. .))
(S (S (NP (ADJP (RB Manually) (VBN measured)) (JJ cross-sectional) (NNS areas)) (VP (VBP are) (ADVP (RBS most) (RB commonly)) (VP (VBN used)))) (, ,) (CC but) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NN consistency))) (VP (VBG regarding) (NP (NP (DT the) (NN position)) (PP (IN of) (NP (DT the)))))) (NN measurementand) (S (NP (JJ manual) (NNS annotations)) (VP (VBP are) (RB not) (ADJP (JJ practical)) (PP (IN for) (NP (JJ large) (NN population) (NNS studies))))))) (. .))
(S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (NP (NP (DT a) (ADJP (RB fully) (VBN automated)) (NN method)) (SBAR (S (VP (TO to) (VP (VB measure) (NP (NP (JJ iliopsoas) (NN muscle) (NN volume)) (PRN (-LRB- -LRB-) (VP (VBN comprised) (PP (IN of) (NP (DT the) (NN psoas) (CC and) (VB iliacus) (NNS muscles)))) (-RRB- -RRB-))) (S (VP (VBG using) (NP (DT a) (JJ convolutional) (JJ neural) (NN network))))))))))) (. .))
(S (NP (JJ Magnetic) (NN resonance) (NNS images)) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (DT the) (NNP UK) (NNP Biobank))) (PP (IN for) (NP (CD 5,000) (NN male) (CC and) (JJ female) (NNS participants))) (, ,) (VP (VBN balanced) (PP (IN for) (NP (NN age) (, ,) (NN gender) (CC and) (NNP BMI)))))) (. .))
(S (NP (NNP Ninety) (JJ manual) (NNS annotations)) (VP (VBD were) (ADJP (JJ available)) (PP (IN for) (NP (NN model) (NN training) (CC and) (NN validation)))) (. .))
(S (NP (DT The) (NN model)) (VP (VBD showed) (NP (NP (JJ excellent) (NN performance)) (PP (IN against) (NP (NP (JJ out-of-sample) (NNS data)) (PRN (-LRB- -LRB-) (NP (NP (NN dice) (RB score) (NN coefficient)) (PP (IN of) (NP (CD 0.912) (JJ +/-) (CD 0.018)))) (-RRB- -RRB-)))))) (. .))
(S (NP (NNP Iliopsoas) (NN muscle) (NNS volumes)) (VP (VBD were) (VP (ADVP (RB successfully)) (VBN measured) (PP (IN in) (NP (QP (DT all) (CD 5,000)) (NNS participants))))) (. .))
(S (NP (NNP Iliopsoas) (NN volume)) (VP (VBD was) (ADJP (JJR greater)) (PP (IN in) (NP (UCP (NP (NN male)) (PP (VBN compared) (PP (IN with) (NP (JJ female))))) (NNS subjects)))) (. .))
(S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (ADJP (JJ small) (CC but) (JJ significant)) (NN asymmetry)) (PP (IN between) (NP (VBN left) (CC and) (JJ right) (NN iliopsoas) (NN muscle) (NNS volumes))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD found) (SBAR (SBAR (IN that) (S (NP (JJ iliopsoas) (NN volume)) (VP (VBD was) (VP (ADVP (RB significantly)) (VBN related) (PP (TO to) (NP (NP (NN height)) (, ,) (NP (NNP BMI)) (CC and) (NP (NN age)))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT an) (NN acceleration)) (PP (IN in) (NP (NN muscle) (NN volume) (NN decrease))) (PP (IN in) (NP (NP (NNS men)) (PP (IN with) (NP (NN age))))))))))) (. .))
(S (NP (PRP$ Our) (NN method)) (VP (VBZ provides) (NP (NP (DT a) (JJ robust) (NN technique)) (PP (IN for) (S (VP (VBG measuring) (NP (JJ iliopsoas) (NN muscle) (NN volume))))) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN applied) (PP (TO to) (NP (JJ large) (NNS cohorts)))))))))) (. .))
